Status:
COMPLETED
Efficacy of Oncoxin Plus Viusid in the Treatment of Rheumatoid Arthritis
Lead Sponsor:
Catalysis SL
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of the study is to assess the efficacy of Oncoxin+Viusid administration in the treatment of rheumatoid arthritis. The duration of this double-blind placebo controlled phase 3 clinical tria...
Eligibility Criteria
Inclusion
- Treatment-naive subjects with recent onset rheumatoid arthritis
- Signed informed consent
Exclusion
- Subjects with rheumatoid arthritis symptoms other than those associated with joints at disease onset
- Subjects with joint function impairment secondary to other conditions not associated with rheumatoid arthritis
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT00969527
Start Date
September 1 2009
End Date
April 1 2011
Last Update
May 9 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fructuoso Rodriguez Orthopedic Hospital
Havana, Cuba, 10400